Skip to content

Rent expense at other companies

Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$10.5K
Evommune
 logo
Evommune EVMN
$2.5K
HWK
HawkinsHWKN
$950K
Southern First Bancshares logo
Southern First BancsharesSFST
$23.25K+2.2%
REX American Resources logo
REX American ResourcesREX
$1.92M-11.5%
Falcon's Beyond Global logo
Falcon's Beyond GlobalFBYD
$117.75K

Other financials

Income statement

See full
Operating income-$19.5M-6.8%
Net income-$19.1M-8.5%
EPS (diluted)-$0.22+62.1%

Balance sheet

See full
Cash & equivalents$9.8M+750%
Total debt$104.1M-40.4%
Total equity$218.7M+875%
Total assets$235.4M+750%

Cash flow

See full
Operating cash flow-$15.1M+16.6%

Valuation

See full
Market cap$677.17M+2,907%

Returns & leverage

See full
Return on equity-48.8%-20.0pp
Debt / equity0.9×0.0×
Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRent.

The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 27, 2025, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s rent expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s rent expense?
Relmada Therapeutics, Inc. (RLMD) reported rent expense of $10.5K in Q2 2024.
What does rent expense mean?
Cash outflows dedicated to the leasing of facilities or equipment necessary for business operations. This metric tracks the fixed cost burden associated with physical infrastructure and real estate commitments.